BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother 2021;146:112530. [PMID: 34915416 DOI: 10.1016/j.biopha.2021.112530] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Parveen N, Abourehab MA, Shukla R, Thanikachalam PV, Jain GK, Kesharwani P. Immunoliposomes as an emerging nanocarrier for breast cancer therapy. European Polymer Journal 2023;184:111781. [DOI: 10.1016/j.eurpolymj.2022.111781] [Reference Citation Analysis]
2 Aziz A, Rehman U, Sheikh A, Abourehab MAS, Kesharwani P. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. J Biomater Sci Polym Ed 2023;34:398-418. [PMID: 36083788 DOI: 10.1080/09205063.2022.2121592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab MAS, Guo W, Huang J, Wang Z, Kesharwani P. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Mol Cancer 2023;22:8. [PMID: 36635659 DOI: 10.1186/s12943-022-01696-5] [Reference Citation Analysis]
4 Sheikh A, Kaur H, Abourehab MA, Alam MS, Kesharwani P. Aptamer-functionalized dendrimers for targeted cancer therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 2023. [DOI: 10.1016/b978-0-323-85881-6.00027-0] [Reference Citation Analysis]
5 Dey A, Kesharwani P, Dubey SK. Actively targeted nanoparticles in photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00014-1] [Reference Citation Analysis]
6 Kar A, Rout SR, Giri L, Sahebkar A, Kesharwani P, Dandela R. Aptamer-functionalized nanoparticles for targeted cancer therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 2023. [DOI: 10.1016/b978-0-323-85881-6.00020-8] [Reference Citation Analysis]
7 Giri L, Rout SR, Gowtham K, Abourehab MA, Kesharwani P, Dandela R. Biomimetic carbon nanotubes for neurological disease therapeutic. Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery 2023. [DOI: 10.1016/b978-0-323-85199-2.00001-7] [Reference Citation Analysis]
8 Kenguva G, Rout SR, Giri L, Sahebkar A, Kesharwani P, Dandela R. Cell-SELEX technology for aptamer selection. Aptamers Engineered Nanocarriers for Cancer Therapy 2023. [DOI: 10.1016/b978-0-323-85881-6.00019-1] [Reference Citation Analysis]
9 Fatima M, Karwasra R, Almalki WH, Sahebkar A, Kesharwani P. Galactose engineered nanocarriers: Hopes and hypes in cancer therapy. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111759] [Reference Citation Analysis]
10 Arab A, Nikpoor AR, Asadi P, Iraei R, Yazdian-robati R, Sheikh A, Kesharwani P. Virus-like nanoparticles (VLPs) based technology in the development of breast cancer ‎vaccines‎. Process Biochemistry 2022;123:44-51. [DOI: 10.1016/j.procbio.2022.10.020] [Reference Citation Analysis]
11 Paloncýová M, Pykal M, Kührová P, Banáš P, Šponer J, Otyepka M. Computer Aided Development of Nucleic Acid Applications in Nanotechnologies. Small 2022;18:e2204408. [PMID: 36216589 DOI: 10.1002/smll.202204408] [Reference Citation Analysis]
12 Arora V, Abourehab MA, Modi G, Kesharwani P. Dendrimers as prospective nanocarrier for targeted delivery against lung cancer. European Polymer Journal 2022;180:111635. [DOI: 10.1016/j.eurpolymj.2022.111635] [Reference Citation Analysis]
13 Fatima M, Abourehab MAS, Aggarwal G, Jain GK, Sahebkar A, Kesharwani P. Advancement of cell-penetrating peptides in combating triple-negative breast cancer. Drug Discov Today 2022;27:103353. [PMID: 36099963 DOI: 10.1016/j.drudis.2022.103353] [Reference Citation Analysis]
14 Singh V, Eljaaly K, Md S, Alhakamy NA, Kesharwani P. Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases. Journal of Drug Delivery Science and Technology 2022;75:103691. [DOI: 10.1016/j.jddst.2022.103691] [Reference Citation Analysis]
15 Rehman U, Parveen N, Sheikh A, Abourehab MAS, Sahebkar A, Kesharwani P. Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer. Colloids Surf B Biointerfaces 2022;218:112766. [PMID: 35994990 DOI: 10.1016/j.colsurfb.2022.112766] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sabit H, Abdel-hakeem M, Shoala T, Abdel-ghany S, Abdel-latif MM, Almulhim J, Mansy M. Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs. Pharmaceutics 2022;14:1566. [DOI: 10.3390/pharmaceutics14081566] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Gupta P, Sheikh A, Abourehab MAS, Kesharwani P. Amelioration of Full-Thickness Wound Using Hesperidin Loaded Dendrimer-Based Hydrogel Bandages. Biosensors 2022;12:462. [DOI: 10.3390/bios12070462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kumar Dubey S, Dabholkar N, Narayan Pal U, Singhvi G, Kumar Sharma N, Puri A, Kesharwani P. Emerging innovations in cold plasma therapy against cancer: a paradigm shift. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.05.014] [Reference Citation Analysis]
20 Nadaf A, Gupta A, Hasan N, Fauziya, Ahmad S, Kesharwani P, Ahmad FJ. Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Adv 2022;12:23808-28. [DOI: 10.1039/d2ra02864f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]